Patents by Inventor John L. Hall

John L. Hall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11931534
    Abstract: A medical insertion device includes an introducer assembly, a needle, and a housing. The introducer assembly includes a dilator coaxially disposed in a sheath, the dilator removably engaged to the sheath in an insertion configuration. The needle is coaxially disposed in the dilator, the needle having a distal tip and a proximal end coupled to a needle hub. The housing may be removably engaged to the dilator. The needle hub is movably disposed in the housing between a first locked position, a second locked position, and a third locked position.
    Type: Grant
    Filed: September 9, 2021
    Date of Patent: March 19, 2024
    Assignee: C. R. Bard, Inc.
    Inventors: John W. Hall, Ryan C. Patterson, Charles L Farnworth
  • Patent number: 11083714
    Abstract: De-ethylflavopereirine, a pharmaceutically acceptable salt thereof, a solvate or a hydrate thereof, or a pharmaceutically acceptable salt of a solvate or a hydrate thereof may be used as cancer therapy (i.e., prevention and/or treatment) in a subject in need thereof, including a pathological condition such as inflammation, especially chronic, or cancer (e.g., a carcinoma, a sarcoma, a melanoma, a leukemia, a lymphoma), especially a solid tumor and/or a metastasis thereof. In particular, systemic administration of such improved anti-cancer agents in effective amounts may selectively destroy cancer cells (including cancer stem cells) in a solid tumor and/or at a site of metastasis. They are well-tolerated by the subject, even at large systemic doses and their resulting high concentrations in the circulation, and provide safe and effective anti-cancer agents.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: August 10, 2021
    Assignee: Molecular International Research, Inc.
    Inventors: John L. Hall, Sylvie P. Beljanski
  • Publication number: 20210015803
    Abstract: De-ethylflavopereirine, a pharmaceutically acceptable salt thereof, a solvate or a hydrate thereof, or a pharmaceutically acceptable salt of a solvate or a hydrate thereof may be used as cancer therapy (i.e., prevention and/or treatment) in a subject in need thereof, including a pathological condition such as inflammation, especially chronic, or cancer (e.g., a carcinoma, a sarcoma, a melanoma, a leukemia, a lymphoma), especially a solid tumor and/or a metastasis thereof. In particular, systemic administration of such improved anti-cancer agents in effective amounts may selectively destroy cancer cells (including cancer stem cells) in a solid tumor and/or at a site of metastasis. They are well-tolerated by the subject, even at large systemic doses and their resulting high concentrations in the circulation, and provide safe and effective anti-cancer agents.
    Type: Application
    Filed: April 1, 2019
    Publication date: January 21, 2021
    Applicant: Molecular International Research, Inc.
    Inventors: John L. HALL, Sylvie P. BELJANSKI
  • Publication number: 20090215853
    Abstract: A method and composition for preventing prostate cancer and/or reducing PSA levels and/or alleviating the symptoms of BPH (Benign Prostatic Hyperplasia) or PIN (prostatic intraepithelial neoplasia) by administration of an effective amount of a mixture of flavopereirine and alstonine. A method and composition for treating low-grade prostate cancer and preventing the onset of metastatic disease and/or reducing the doubling time of PSA levels in men with positive biopsies showing relatively low Gleason scores and morphologies characteristic of non-invasive, slow-progressing prostate cancer. The flavopereirine and alstonine can be in the form of natural extracts derived from Pao Pereira and Rauwolfia Vomitoria, respectively. Alternatively, these two active compounds can be administered in purified form. The composition can be in included in a kit along with instructions for use in a treatment regimen.
    Type: Application
    Filed: May 19, 2005
    Publication date: August 27, 2009
    Applicant: Natural Source International
    Inventors: John L. Hall, Sylvie Beljanski
  • Patent number: 7469454
    Abstract: A technique for reducing the vibration sensitivity of laser-stabilizing optical reference cavities is based upon an improved design and mounting method for the cavity, wherein the cavity is mounted vertically. It is suspended at one plane, around the spacer cylinder, equidistant from the mirror ends of the cavity. The suspension element is a collar of an extremely low thermal expansion coefficient material, which surrounds the spacer cylinder and contacts it uniformly. Once the collar has been properly located, it is cemented in place so that the spacer cylinder is uniformly supported and does not have to be squeezed at all. The collar also includes a number of cavities partially bored into its lower flat surface, around the axial bore. These cavities are support points, into which mounting base pins will be inserted. Hence the collar is supported at a minimum of three points.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: December 30, 2008
    Assignees: Regents of the University of Colorado, The United States of America as represented by the Secretary of Commerce, the National Institute of Standards and Technology
    Inventors: Mark Notcutt, John L. Hall, Long-Sheng Ma
  • Patent number: 7341749
    Abstract: A method and composition for preventing prostate cancer and/or reducing PSA levels and/or alleviating the symptoms of BPH (Benign Prostatic Hyperplasia) or PIN (prostatic intraepithelial neoplasia) by administration of an effective amount of a mixture of flavopereirine and alstonine. A method and composition for treating low-grade prostate cancer and preventing the onset of metastatic disease and/or reducing the doubling time of PSA levels in men with positive biopsies showing relatively low Gleason scores and morphologies characteristic of non-invasive, slow-progressing prostate cancer. The flavopereirine and alstonine can be in the form of natural extracts derived from Pao Pereira and Rauwolfia Vomitoria, respectively. Alternatively, these two active compounds can be administered in purified form. The composition can be in included in a kit along with instructions for use in a treatment regimen.
    Type: Grant
    Filed: May 19, 2005
    Date of Patent: March 11, 2008
    Assignee: Natural Source International Ltd.
    Inventors: John L. Hall, Sylvie P. Beljanski
  • Patent number: 6850543
    Abstract: Disclosed is a system and method for stabilizing the carrier-envelope phase of the pulses emitted by a femtosecond mode-locked laser by using the powerful tools of frequency-domain laser stabilization. Control of the pulse-to-pulse carrier-envelope phases was confirmed using temporal cross correlation. This phase stabilization locks the absolute frequencies emitted by the laser, which is used to perform absolute optical frequency measurements that were directly referenced to a stable microwave clock.
    Type: Grant
    Filed: March 29, 2001
    Date of Patent: February 1, 2005
    Assignee: The United States of America as represented by the Secretary of Commerce
    Inventors: Steven T. Cundiff, John L. Hall, Scott A. Diddams, David J. Jones
  • Patent number: 6831935
    Abstract: Accurate and efficient synchronization of two pulsed radiation sources (e.g. iwo mode locked lasers) is accomplished in stages. Rough synchronization is accomplished by synchronizing (for example) the fundamental repetition rate of the two lasers. Fine synchronization is accomplished by synchronizing high harmonics of the two lasers. More accurate synchronization may be accomplished by adding more stages, by utilizing light out of a nonlinear laser in which the two beams are crossed, or by utilizing heterodyne beats of the two laser beams. A dc offset signal may added to the control signal generated by the synchronization stages.
    Type: Grant
    Filed: March 29, 2002
    Date of Patent: December 14, 2004
    Assignee: The Regents of the University of Colorado
    Inventors: Jun Ye, Henry C. Kapteyn, John L. Hall, Robert K. Shelton, Margaret Murnane, Long-Sheng Ma
  • Patent number: 6727492
    Abstract: An ac technique for cavity ringdown spectroscopy permits 1×10−10 absorption sensitivity with microwatt light power. Two cavity modes are provided temporally out of phase such that when one mode is decaying, the other mode is rising. When one of the modes probes intra-cavity absorption of a sample gas, heterodyne detection between the two modes reveals dynamic time constants associated with the cavity and the cavity plus intra-cavity absorption. The system and method provides a quick comparison between on-resonance and off-resonance modes and enables sensitivities that approach the shot-noise limit.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: April 27, 2004
    Assignees: Regents of the University of Colorado, The United States of America as represented by the Secretary of Commerce
    Inventors: Jun Ye, John L. Hall
  • Publication number: 20040065816
    Abstract: An ac technique for cavity ringdown spectroscopy permits 1×10−10 absorption sensitivity with microwatt light power. Two cavity modes are provided temporally out of phase such that when one mode is decaying, the other mode is rising. When one of the modes probes intra-cavity absorption of a sample gas, heterodyne detection between the two modes reveals dynamic time constants associated with the cavity and the cavity plus intra-cavity absorption. The system and method provides a quick comparison between on-resonance and off-resonance modes and enables sensitivities that approach the shot-noise limit.
    Type: Application
    Filed: January 12, 2001
    Publication date: April 8, 2004
    Inventors: Jun Ye, John L. Hall
  • Publication number: 20040017833
    Abstract: Disclosed is a system and method for stabilizing the carrier-envelope phase of the pulses emitted by a femtosecond mode-locked laser by using the powerful tools of frequency-domain laser stabilization. Control of the pulse-to-pulse carrier-envelope phases was confirmed using temporal cross correlation. This phase stabilization locks the absolute frequencies emitted by the laser, which is used to perform absolute optical frequency measurements that were directly referenced to a stable microwave clock.
    Type: Application
    Filed: September 27, 2002
    Publication date: January 29, 2004
    Inventors: Steven T. Cundiff, John L. Hall, Scott A. Diddams, David J. Jones
  • Publication number: 20030185255
    Abstract: Accurate and efficient synchronization of two pulsed radiation sources (e.g. iwo mode locked lasers) is accomplished in stages. Rough synchronization is accomplished by synchronizing (for example) the fundamental repetition rate of the two lasers. Fine synchronization is accomplished by synchronizing high harmonics of the two lasers. More accurate synchronization may be accomplished by adding more stages, by utilizing light out of a nonlinear laser in which the two beams are crossed, or by utilizing heterodyne beats of the two laser beams. A dc offset signal may added to the control signal generated by the synchronization stages.
    Type: Application
    Filed: March 29, 2002
    Publication date: October 2, 2003
    Inventors: Jun Ye, Henry C. Kapteyn, John L. Hall, Robert K. Shelton, Margaret Murnane, Long-Sheng Ma
  • Patent number: 6348174
    Abstract: Infectious wastes originating in hospitals or other locations are deposited into a sealable, pressure resistant, portable sterilizer vessel at the source of the wastes. The sterilizer vessel rides on wheels enabling travel of the filled vessel to a sterilization station at another location where steam is directed into the vessel to perform the sterilization. Operators need not transfer unprocessed infectious waste from a collection cart to a fixed sterilization vessel at the sterilization site. In the preferred form, handler exposure to unprocessed wastes is further reduced by creating an airflow from the vessel opening to a filter while the vessel is opened for deposit of wastes.
    Type: Grant
    Filed: December 6, 1999
    Date of Patent: February 19, 2002
    Inventor: John L. Hall
  • Patent number: 5772133
    Abstract: A revolving trommel situated adjacent to a shredder has an annular screen which intercepts oversized or elongated fragments in the outflow from the shredder for return to the shredder. A first fragment guide directs the shredder outflow into the trommel and vanes in the trommel lift the oversized fragments to another fragment guide which extends out of the trommel to the shredder intake. In the preferred form, the trommel rests upon and is turned by a motor driven flexible continuous belt which carries fragments that pass through the screen upward to an elevated discharge chute. The apparatus is particularly useful for fragmentizing sterilized medical wastes.
    Type: Grant
    Filed: October 2, 1995
    Date of Patent: June 30, 1998
    Assignees: Darlene Hall, Wilburn E. Hall, Vern W. Hall
    Inventor: John L. Hall
  • Patent number: 5746988
    Abstract: Infectious wastes from hospitals or other sources are sterilized in a chamber which is pivotable between a waste loading orientation, a sterilizing orientation and a waste dumping orientation. The chamber is attached to a framework by first and second pairs of pivot arms which are coupled to the sides of the chamber at spaced apart locations. An actuator swings the first arms upward to bring the chamber to the loading orientation and swings the arms downward to turn the chamber to the dumping orientation. The pivot arm arrangement causes the chamber as a whole to lower as it turns towards the loading orientation and to rise as it turns towards the dumping orientation. This reduces the amount of lifting of materials that is required during loading operations while also providing adequate clearance under the chamber for dumping operations.
    Type: Grant
    Filed: November 24, 1995
    Date of Patent: May 5, 1998
    Assignees: Darlene Hall, Wilburn E. Hall, Vern W. Hall
    Inventor: John L. Hall
  • Patent number: 5614157
    Abstract: Apparatus for treating infectious wastes from hospitals, medical clinics or the like integrates sterilizing, fragmentizing and compaction steps within a single waste processor. Wastes which are deposited in a sterilization chamber are made non-infectious by exposure to pressurized steam. An outflow of wastes from the sterilization chamber is fed through one or more on-line shredders or the like and then into a compactor which compresses the processed material into a transportable container that may be hauled to a dump site.
    Type: Grant
    Filed: December 22, 1994
    Date of Patent: March 25, 1997
    Assignees: Darlene Hall, Wilburn E. Hall, Vern W. Hall
    Inventor: John L. Hall
  • Patent number: 5470546
    Abstract: A fluid tight waste materials receptacle is located within a housing which has an upper access opening through which infectious wastes from medical clinics or the like may be deposited in the receptacle. A lower access opening enables entry and withdrawal of a sterilized waste receiver which may, for example, be a wheeled cart. The receptacle has an open end and a closed end and is pivotable between a first orientation at which the open end is coincident with the upper access opening in order to receive wastes and a second orientation at which the open end is turned downward to discharge wastes into the receiver. A closure pivoted to the housing seats in and seals the open end of the receptacle when it is at the first orientation. The receptacle is periodically evacuated and steam is admitted to sterilize the contents prior to discharge into the receiver.
    Type: Grant
    Filed: June 24, 1994
    Date of Patent: November 28, 1995
    Inventor: John L. Hall
  • Patent number: 5437414
    Abstract: Apparatus for fragmentizing objects recovers and reprocesses oversized fragments. A shredder is encircled by an annular trommel revolving about a horizontal axis of rotation and which extends over the shredder intake hopper and below the fragment outlet. Fragments which are too large to pass through apertures in the trommel are carried upward by vanes on the trommel and returned to the intake hopper. In one form of the apparatus, a fragment guide has a curved surface extending along at least a lower portion of the trommel and which is spaced from the trommel to allow small fragments to pass through the trommel apertures. Cleats on the trommel urge such fragments towards a fragment discharging end of the guide. Thin elongated fragments which attempt to pass through a trommel aperture are stopped by the presence of the guide and thus are also carried upward and returned to the intake for further processing.
    Type: Grant
    Filed: June 27, 1994
    Date of Patent: August 1, 1995
    Inventor: John L. Hall
  • Patent number: 5389347
    Abstract: Hospital wastes or the like are sterilized and compressed for disposal by apparatus having a waste receptacle with a waste receiving opening at the top and having a sterilizer casing, the receptacle and casing being in telescoping relationship. The receptacle initially protrudes from the casing in order to receive the wastes and is then translated into the casing to close the casing and thereby enable sterilization of the contents by admission of pressurized steam. A helical rotary conveyer extends along the axis of the receptacle and has several functions. The conveyer moves wastes from the receptacle into the casing and precompacts such wastes prior to the sterilization cycle and may be used to stir the wastes during sterilization. After opening of a casing door, the conveyer operates to discharge the sterile wastes from the casing and a translatable ram forces the material into an adjacent compactor container.
    Type: Grant
    Filed: October 1, 1993
    Date of Patent: February 14, 1995
    Assignee: Bromac Enterprises
    Inventor: John L. Hall
  • Patent number: 5218426
    Abstract: A highly accurate in-situ determination of the refractivity of an ambient atmosphere is disclosed, which determination is utilizable to enhance the accuracy of a quantity measurement. The system includes use of a refractometer exposed to an ambient atmosphere and having light directed thereto to form an optical interference fringe pattern having a dependence upon the refractivity of the ambient atmosphere. The fringe pattern is measured as a function of angle either by sequentially scanning a collimated input beam in angle while collecting and detecting the transmitted light, or by imaging (onto a multi-element detector) the angular exit space of the interferometer illuminated with a diverging input beam. The electrical output of the detector is processed to provide an output indicative of the index of refraction of the ambient atmosphere.
    Type: Grant
    Filed: July 1, 1991
    Date of Patent: June 8, 1993
    Assignee: The United States of America as represented by the Secretary of Commerce
    Inventors: John L. Hall, Peter J. Martin, Mark L. Eickhoff, Michael P. Winters